Literature DB >> 26421262

Obesity and liver transplantation.

Subhashini Ayloo1, John Armstrong1, Scott Hurton1, Michele Molinari1.   

Abstract

The percentage of overweight and obese patients (OPs) waiting for a liver transplant continues to increase. Despite the significant advances occurred in bariatric medicine, obesity is still considered a relative contraindication to liver transplantation (LT). The main aim of this review is to appraise the literature on the outcomes of OPs undergoing LT, treatments that might reduce their weight before, during or after surgery, and discuss some of the controversies and limitations of the current knowledge with the intent of highlighting areas where future research is needed.

Entities:  

Keywords:  Access to transplantation; Bariatric surgery; End-stage liver disease; Liver transplantation; Obesity; Weight-loss

Year:  2015        PMID： 26421262      PMCID： PMC4580932          DOI： 10.5500/wjt.v5.i3.95

Source DB:  PubMed          Journal:  World J Transplant        ISSN： 2220-3230


  41 in total

1.  Orlistat decreases the plasma level of cyclosporine and may be responsible for the development of acute rejection episodes.

Authors:  B Schnetzler; M Kondo-Oestreicher; D Vala; G Khatchatourian; B Faidutti
Journal:  Transplantation       Date:  2000-11-27       Impact factor: 4.939

2.  Use of laparoscopy in general surgical operations at academic centers.

Authors:  Ninh T Nguyen; Brian Nguyen; Anderson Shih; Brian Smith; Samuel Hohmann
Journal:  Surg Obes Relat Dis       Date:  2012-07-16       Impact factor: 4.734

3.  Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial.

Authors:  Florencia Halperin; Su-Ann Ding; Donald C Simonson; Jennifer Panosian; Ann Goebel-Fabbri; Marlene Wewalka; Osama Hamdy; Martin Abrahamson; Kerri Clancy; Kathleen Foster; David Lautz; Ashley Vernon; Allison B Goldfine
Journal:  JAMA Surg       Date:  2014-07       Impact factor: 14.766

Review 4.  Cardiovascular benefits of bariatric surgery in morbidly obese patients.

Authors:  V G Athyros; K Tziomalos; A Karagiannis; D P Mikhailidis
Journal:  Obes Rev       Date:  2011-02-23       Impact factor: 9.213

5.  Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes.

Authors:  Philip R Schauer; Deepak L Bhatt; John P Kirwan; Kathy Wolski; Stacy A Brethauer; Sankar D Navaneethan; Ali Aminian; Claire E Pothier; Esther S H Kim; Steven E Nissen; Sangeeta R Kashyap
Journal:  N Engl J Med       Date:  2014-03-31       Impact factor: 91.245

6.  Laparoscopic sleeve gastrectomy is safe and efficacious for pretransplant candidates.

Authors:  Matthew Y C Lin; M Mehdi Tavakol; Ankit Sarin; Shadee M Amirkiai; Stanley J Rogers; Jonathan T Carter; Andrew M Posselt
Journal:  Surg Obes Relat Dis       Date:  2013-03-21       Impact factor: 4.734

Review 7.  Sleeve gastrectomy for morbid obesity.

Authors:  Andrew A Gumbs; Michel Gagner; Gregory Dakin; Alfons Pomp
Journal:  Obes Surg       Date:  2007-07       Impact factor: 4.129

8.  Liver transplantation at the extremes of the body mass index.

Authors:  André A S Dick; Austin L Spitzer; Catherine F Seifert; Alysun Deckert; Robert L Carithers; Jorge D Reyes; James D Perkins
Journal:  Liver Transpl       Date:  2009-08       Impact factor: 5.799

9.  Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease.

Authors:  J K Heimbach; K D S Watt; J J Poterucha; N Francisco Ziller; S D Cecco; M R Charlton; J E Hay; R H Wiesner; W Sanchez; C B Rosen; J M Swain
Journal:  Am J Transplant       Date:  2012-11-08       Impact factor: 8.086

Review 10.  The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.

Authors:  J Picot; J Jones; J L Colquitt; E Gospodarevskaya; E Loveman; L Baxter; A J Clegg
Journal:  Health Technol Assess       Date:  2009-09       Impact factor: 4.014
View more
  5 in total

Review 1.  Nonalcoholic Fatty Liver Disease: Key Considerations Before and After Liver Transplantation.

Authors:  Yuval A Patel; Carl L Berg; Cynthia A Moylan
Journal:  Dig Dis Sci       Date:  2016-01-27       Impact factor: 3.199

2.  Reexamining the Association of Body Mass Index With Overall Survival Outcomes After Liver Transplantation.

Authors:  Su-Hsin Chang; Xiaoyan Liu; Nils P Carlsson; Yikyung Park; Graham A Colditz; Jacqueline M Garonzik-Wang; William C Chapman; Jason R Wellen; Maria B Doyle; Tarek Alhamad
Journal:  Transplant Direct       Date:  2017-06-12

3.  Trends of characteristics and outcomes of donors and recipients of deceased donor liver transplantation in the United States: 1990 to 2013.

Authors:  Subhashini Ayloo; Sri Ram Pentakota; Michele Molinari
Journal:  World J Transplant       Date:  2018-09-10

4.  Hepatocellular carcinoma and metabolic syndrome: The times are changing and so should we.

Authors:  Georgios Tsoulfas
Journal:  World J Gastroenterol       Date:  2019-08-07       Impact factor: 5.742

Review 5.  Clinical considerations in the management of non-alcoholic steatohepatitis cirrhosis pre- and post-transplant: A multi-system challenge.

Authors:  Justin A Steggerda; Krishnaraj Mahendraraj; Tsuyoshi Todo; Mazen Noureddin
Journal:  World J Gastroenterol       Date:  2020-07-28       Impact factor: 5.742
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.